Search For "fda"
US approved 4 COVID-19 vaccine candidates for clinical trials - FDA Head
Updated : 5 years, 8 months ago IST
Washington [US], July 1 (Sputnik/ANI): The United States has approved four coronavirus vaccine candidates for clinical trials, Food and Drug Administration (FDA) head Stephen Hahn told reporters.
Read More
US left with 63 million doses of anti-malarial drug after FDA revoked its
Updated : 5 years, 9 months ago IST
Washington D.C. [USA], June 19 (ANI): The US federal government is now left with 63 million doses of hydroxychloroquine sulfate (HCQ) in its stockpile after the Food and Drug Administration (FDA) earlier this week, revoked the permission for use of anti-malarial drug in treating COVID-19
Read More
MedAlliance gains CE Mark approval for coronary SELUTION SLR™ Siroli
Updated : 5 years, 9 months ago IST
Mumbai (Maharashtra) [India] June 16 (ANI/PRNewswire): MedAlliance has announced the award of its second CE Mark: SELUTION SLR™ 014 PTCA, a novel Sirolimus Drug Eluting Balloon (DEB), for the treatment of coronary arterial disease.
Read More
US FDA revokes emergency authorisation for HCQ championed by President Tru
Updated : 5 years, 9 months ago IST
Washington D.C. [US], June 15 (ANI): The US Food and Drug Administration (FDA) on Monday revoked the emergency use authorization for malaria drug hydroxychloroquine (HCQ) as a treatment for COVID-19, the use of which has been championed by President Donald Trump.
Read More
Zydus signs licensing agreement with Gilead to manufacture and market Remd
Updated : 5 years, 9 months ago IST
Ahmedabad (Gujarat) [India], June 13 (ANI): Healthcare major Zydus Cadila has signed a non-exclusive licensing agreement with Gilead Sciences Inc for the manufacturing and distribution of Remdesivir, the investigational drug which has been issued an emergency use authorisation by the US Food
Read More
PerkinElmer receives commercial approval from the Central Drugs Standard C
Updated : 5 years, 9 months ago IST
New Delhi [India] June 10 (ANI/BusinessWire India): PerkinElmer, Inc, a global leader committed to innovating for a healthier world, today announced that PerkinElmer India has received commercial approval by the Central Drugs Standard Control Organization (CDSCO) for the PerkinElmer new coro
Read More
Trump says he has been taking Hydroxychloroquine despite FDA warning
Updated : 5 years, 10 months ago IST
Washington D.C. [US], May 19 (ANI): US President Donald Trump on Monday (local time) said he is taking hydroxychloroquine, a drug that he often touted as a potential treatment for coronavirus.
Read More
Hydroxychloroquine --promoted by Trump as Covid 'game changer'-- linked to
Updated : 5 years, 10 months ago IST
Washington D.C. [USA], May 17 (ANI): Clinical trials of the anti-malarial drug or hydroxychloroquine, which gained prominence overnight after being promoted by US President Donald Trump as a 'game changer' in the fight against Covid-19, have been significantly linked to cardiac problems and
Read More
Vestige expands health and wellness portfolio, launches Vestige Prime Meta
Updated : 5 years, 10 months ago IST
New Delhi [India] May 14 (ANI/BusinessWire India): Vestige Marketing Pvt Ltd, one of India's leading direct selling companies that provides health, wellness, and hygiene products has launched Vestige Prime Metamind chewable tablets.
Read More
COVID-19: Cipla enters into licensing pact with Gilead to manufacture and
Updated : 5 years, 10 months ago IST
Mumbai (Maharashtra) [India], May 13 (ANI): Pharmaceutical major Cipla said on Wednesday it has signed a non-exclusive licensing agreement with Gilead Sciences Inc for manufacturing and distributing investigational medicine Remdesivir which has been issued an emergency use authorisation by t
Read More
US approves antigen test to diagnose COVID-19
Updated : 5 years, 10 months ago IST
Washington (US), May 10 (ANI: The US Food and Drug Administration (FDA) has authorized the use of antigen test for the first time to detect and treat COVID-19 infection.
Read More
CSIR to begin two clinical drug trials to combat COVID-19
Updated : 5 years, 10 months ago IST
New Delhi [India], May 8 (ANI): The Council for Scientific and Industrial Research (CSIR) has received approval from Drug Controller General of India (DGCI) for its two clinical trial drugs - 'favipiravir' and 'phytopharmaceutical' - to combat coronavirus.
Read More